Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients

Clinical trial NCT01657214 · COMPLETED

Trial details

NCT number: NCT01657214
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2012-09-01
Primary completion: 2016-01-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.